Skip to main content
S&P 5007,722.72+0.73%DOW51,176.96+0.49%NASDAQ27,190.86+1.19%BTC$84,654.00-0.13%ETH$2,677.39-1.09%GOLD$4,172.10-0.72%OIL$91.26-1.73%
Smart Investors Daily
SID Premium
SRx Health Solutions Inc. logo

NYSE · SRXH

SRx Health Solutions Inc.

Healthcare · Drug Manufacturers - General

$1.61

Up+$0.00 (+0.00%)

Updated Oct 4, 2026, 7:26 AM

SID Score

3.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
12.92M
P/E ratio
-0.67
Dividend yield
3.11%
52-week range
$0.96 – $42.61
Volume
475.49K
Avg. volume
892.09K

Price performance · SRXH

SRXH price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Oct 2, 2026

SRXH closed at $1.61 after 19 trading sessions, up 1.90% for the selected period.

Last close
$1.61
Period change
+1.90%
Period low
$1.51
Period high
$1.78
Daily close
View OHLC price history
SRXH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 2, 2026$1.62$1.6401$1.58$1.61475.49K
Oct 1, 2026$1.56$1.635$1.50$1.61627.09K
Sep 30, 2026$1.58$1.60$1.55$1.55247.12K
Sep 29, 2026$1.69$1.69$1.58$1.60401.13K
Sep 28, 2026$1.68$1.68$1.575$1.58514.03K
Sep 25, 2026$1.73$1.79$1.675$1.701.06M
Sep 24, 2026$1.70$1.7901$1.6924$1.73758.6K
Sep 23, 2026$1.77$1.82$1.68$1.70880.46K
Sep 22, 2026$1.74$1.83$1.68$1.78921.28K
Sep 21, 2026$1.72$1.85$1.66$1.721.16M
Sep 18, 2026$1.64$1.79$1.64$1.671.15M
Sep 17, 2026$1.63$1.6584$1.57$1.62365.53K
Sep 16, 2026$1.70$1.72$1.57$1.60469.35K
Sep 15, 2026$1.65$1.72$1.6266$1.71438.68K
Sep 14, 2026$1.58$1.6993$1.56$1.68881.22K
Sep 11, 2026$1.58$1.665$1.55$1.59571.27K
Sep 10, 2026$1.48$1.64$1.47$1.56989.48K
Sep 9, 2026$1.56$1.60$1.51$1.51452.37K
Sep 8, 2026$1.51$1.60$1.51$1.58358.13K

Latest SRXH news

The latest Smart Investors Daily articles mentioning SRXH.

Stock researchCompany · Overview

SRXH research

Overview

Company profile and research snapshot.

Company profile

SRX HealthSolutions Inc operates the continuing pet health and wellness business under the Halo brand, offering premium and super-premium foods, treats, toppers, chews, dental products and supplements for dogs and cats. The company provides high-quality pet products formulated to meet high-quality sourcing and nutritional standards and produced through co-manufacturing relationships. Its Consumer Products segment includes the legacy Halo pet food business with premium products such as dry kibble, wet food, freeze-dried raw food, treats and toppers. Products are sold across e-commerce platforms such as Amazon and Chewy, select retail partners, and international distributors, with operations mainly in the United States, Taiwan and other markets.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 24, 2026

SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)

SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, with multiple potential applications in defense, ranging from drones for facial recognition to body cameras.NORTH PALM BEACH, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operat

Yahoo · Sep 23, 2026

SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar

NORTH PALM BEACH, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that SRX Global’s CEO, Kent Cunningham, and President, EMJX Platform and Head of Asset Management, Eric Jackson, will present at the Webull Corporate Connect Series Fintech Investment Webinar, a live inves

Yahoo · Sep 3, 2026

SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company

NORTH PALM BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today is providing shareholders with an update on its portfolio company ARMR Sciences (“ARMR”), a clinical-stage biodefense company developing a platform of medical countermeasures against synthetic drugs, such as fentany

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By